Health department outlines strategy to eliminate cervical cancer by 2030
A shift to single-dose HPV vaccines and expanded screening targets form part of a national drive to avert thousands of deaths and meet global health milestones.
South Africa has reaffirmed its commitment to eliminating cervical cancer by 2030, aligning with the World Health Organization’s (WHO) global strategy.
On World Cervical Cancer Elimination Day yesterday, the department of health joined the global community in raising awareness of a disease that remains one of the leading causes of cancer deaths among South African women, despite being largely preventable through vaccination, screening and early treatment.
Read more: Bryanston teen living with bone cancer fulfils dream of meeting Siya Kolisi
In 2024, an estimated 8 382 women were diagnosed with cervical cancer, while approximately one woman died from the disease every 67 minutes. These figures underline the urgent need to strengthen prevention, early detection, treatment and follow-up care.
South Africa’s Cervical Cancer Elimination Strategy 2026–2030 provides a co-ordinated national roadmap to accelerate progress towards the WHO’s 90–70–90 targets: vaccinating 90% of girls against human papillomavirus (HPV) by age 15, screening 70% of women with a high-performance test at ages 35 and 45, and ensuring that 90% of women diagnosed with cervical disease receive appropriate treatment.
HPV vaccination remains the foundation of prevention. Since the school-based programme began in 2014, millions of girls have received protection against the virus responsible for almost all cases of cervical cancer. In line with updated WHO recommendations, South Africa has moved from a two-dose to a single-dose schedule to improve efficiency and expand coverage.
The department has broadened access by including girls aged nine attending private schools and is strengthening efforts to reach girls missed in previous campaigns.
Also read: Redhill educator highlights the importance of a supportive school community
During the February–March 2026 school vaccination campaign, 428 395 girls in grades five to seven received the HPV vaccine, achieving 90.6% campaign coverage, with six provinces exceeding 90%.
Recognising the higher risk faced by women living with HIV, the department will continue to assess strategies to strengthen prevention and care for higher-risk populations.
South Africa is expanding access to HPV DNA testing across all provinces and strengthening treatment for women with precancerous lesions.
Working with partners, including the Clinton Health Access Initiative and Unitaid, the department is scaling up thermal ablation equipment and improving the integration of screening and treatment to reduce loss to follow-up.
Integrated screening and treatment models are being piloted at Ceza Hospital in KwaZulu-Natal and Mofolo Community Health Centre in Gauteng. Between April and September 2026, women screened rose from 869 to 1 086 at Ceza and from 431 to 1 266 at Mofolo compared with the same period in 2025. These results show the value of stronger patient pathways, active follow-up and targeted service delivery.
To expand treatment for precancerous lesions, the department is supporting decentralisation of services. In September, 201 thermal ablation devices and 24 LLETZ machines were secured to increase capacity and bring services closer to communities, particularly in underserved areas.
Women’s access to timely diagnosis and treatment remains central. The department continues to invest in oncology infrastructure, strengthen referral pathways and expand treatment capacity.
Also read: Mediclinic Sandton offers free CPR training
Capacity-building for health workers includes a series of webinars that began in October this year.
The 2026 national cervical cancer investment case estimates that the current service package costs approximately R3.1b annually, with about 77% spent on treating invasive cancer. The accelerated scenario to achieve the 90–70–90 targets by 2030 models an additional R3.42b investment over the 2027/28 to 2029/30 period.
Compared with maintaining current coverage, the model projects that approximately 19 500 cervical cancer cases and 15 900 deaths could be averted over 15 years.
Achieving elimination will require a whole-of-society response involving government, civil society, development partners, healthcare professionals, researchers, the private sector and communities.
The department calls on all South Africans to support prevention by encouraging HPV vaccination, promoting regular screening and helping women access timely care.
Through sustained leadership, strong partnerships and collective action, South Africa can eliminate cervical cancer as a public health problem and save thousands of lives.
Follow us on our Whatsapp channel, Facebook, X, Instagram and TikTok for the latest updates!



